Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Idiopathic interstitial pneumonias (IIPs) have a progressive and often fatal course, and their enigmatic etiology has complicated approaches to effective therapies. Idiopathic pulmonary fibrosis (IPF) is the most common of IIPs and shares with IIPs an increased incidence with age and unexplained scarring in the lung. Short telomeres limit tissue renewal capacity in the lung and germ-line mutations in telomerase components, hTERT and hTR , underlie inheritance in a subset of families with IPF. To examine the hypothesis that short telomeres contribute to disease risk in sporadic IIPs, we recruited patients who have no family history and examined telomere length in leukocytes and in alveolar cells. To screen for mutations, we sequenced hTERT and hTR. We also reviewed the cases for features of a telomere syndrome. IIP patients had shorter leukocyte telomeres than age-matched controls ( P < 0.0001). In a subset (10%), IIP patients had telomere lengths below the first percentile for their age. Similar to familial cases with mutations, IPF patients had short telomeres in alveolar epithelial cells ( P < 0.0001). Although telomerase mutations were rare, detected in 1 of 100 patients, we identified a cluster of individuals (3%) with IPF and cryptogenic liver cirrhosis, another feature of a telomere syndrome. Short telomeres are thus a signature in IIPs and likely play a role in their age-related onset. The clustering of cryptogenic liver cirrhosis with IPF suggests that the telomere shortening we identify has consequences and can contribute to what appears clinically as idiopathic progressive organ failure in the lung and the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, patients with IPF who have mutant telomerase genes are at an increased risk of developing bone marrow failure and liver disease54,71.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, telomere dysfunction in epithelial cells, or perhaps another cell type, might cause parenchymal organ remodelling, which manifests as fibrosis and/or emphysema46,54,99.”
From The telomere syndromes (2012) · cites this paper as [54]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Moreover, circulating leukocytes and alveolar epithelial cells show shorter telomeres than age-matched individuals53.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [53]
The cited source says what the claim attributes to it.
In the citing paper
“The frequency of these mutations is highest in individuals with the progressive disorder IPF, which accounts for 8–15% of familial and 1–3% of sporadic cases54,56,68,69.”
From The telomere syndromes (2012) · cites this paper as [54]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Lead SNPs at two loci (TERC and TERT) associate with several cancers and other diseases, including idiopathic pulmonary fibrosis.”
From Identification of seven loci affecting mean telomere length and their association with disease (2013) · cites this paper as [26]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 6×
“In IPF families with telomerase mutations, cases of aplastic anemia can be hidden and are uncovered after a thorough family history, suggesting that mutations in telomerase have heterogeneous manifestations in an individual patient and within families, and that a subset of families with IPF falls on the same spectrum…”
BackgroundInfluentialSelf-citationEssential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168
Greider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150
Cited by
Items 401–500 of 802
Evidence of telomere attrition and a potential role for DNA damage in systemic sclerosis
Usategui, A., Municio, C., Arias‐Salgado, E. G., Martín, M. J., Fernández-Varas, B., Rey, M. J. D., Carreira, P. E., Gonzalez, A., Criado, G., Perona, R., et al. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00263-2 · Cited by 24
“Mutations of telomerase and shelterin genes are associated with TS and represent the most common genetic factor associated with familial idiopathic pulmonary fibrosis and less frequently with sporadic forms of adult-onset pulmonary fibrosis [3, 4].”
BackgroundSnyder, M. E., Anderson, M. R., Benvenuto, L. J., Sutton, R. M., Bondonese, A., Koshy, R., Burke, R., Clifford, S., Craig, A., Iasella, C. J., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2023.08.001 · Cited by 27
Self-citationPersonalized Medicine: Applying ‘omics’ to Lung Fibrosis
Herazo‐Maya, J. D., & Kaminski, N. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.38 · Cited by 25
Antoniou, K. M., Margaritopoulos, G. A., Proklou, Α., Karagiannis, K., Lasithiotaki, I., Soufla, G., Kastrinaki, M.-C., Spandidos, D. A., Papadaki, H. Α., & Siafakas, N. M. (2012) · Journal of Inflammation · doi:10.1186/1476-9255-9-27 · Cited by 24
“On the other hand, mutations in the essential telomerase genes are also present in 1-3% of sporadic cases [30,37].”
Carulli, L., Dei, A., & Nascimbeni, F. (2012) · Hepatology · doi:10.1002/hep.26089 · Cited by 24
Patient considerations and drug selection in the treatment of idiopathic pulmonary fibrosis
Hart, S. P., Trawinska, M., & Rupesinghe, R. (2016) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s81144 · Cited by 27
“evidence to suggest that there may be failed cellular regeneration, mediated by shortened telomere length.(5) Abnormal mucin production may be involved in the development of fibrosis, either through impairing host defense systems or disrupting normal alveolar repair mechanisms.”
BackgroundDysfunctional telomeres and hematological disorders
Fiorini, E., Santoni, A., & Colla, S. (2018) · Differentiation · doi:10.1016/j.diff.2018.01.001 · Cited by 26
“Although this mutation slightly decreases telomerase activity (the telomerase activity of the A1062T allele has been reported to be normal or reduced to 60% of wild type (Alder et al., 2008; Calado et al., 2009)), it still affects telomere length and predisposes cells to genomic instability, probably in combination wi…”
BackgroundCellular senescence in normal and premature lung aging
Bartling, B. (2013) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-013-0543-3 · Cited by 26
The Importance of Detailed Epigenomic Profiling of Different Cell Types within Organs
Stueve, T. R., Marconett, C. N., Zhou, B., Borok, Z., & Laird‐Offringa, I. A. (2016) · Epigenomics · doi:10.2217/epi-2016-0005 · Cited by 26
Kishore, A., Žižková, V., Kocourková, L., Petřková, J., Bouros, E., Nunès, H., Lošťáková, V., Müller–Quernheim, J., Zissel, G., Kolek, V., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00274 · Cited by 26
“Several studies have reported the telomerase gene mutation causing short telomerase as risk factor and poor survival in IPF (2, 30, 31).”
BackgroundPAI-1: A New Target for Controlling Lung-Cell Senescence and Fibrosis?
Adnot, S., Breau, M., & Houssaini, A. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0341ed · Cited by 25
“Proof that lung-cell senescence induces lung fibrosis comes from the observation that a substantial proportion of individuals who exhibit accelerated cell senescence due to a mutation in the TERT (telomerase reverse transcriptase) gene develop lung fibrosis (8).”
BackgroundFang, C., Huang, H. F., Zhang, Q., Wang, N., Jing, X., Guo, J., Ferianc, M., & Xu, Z. (2020) · Respirology · doi:10.1111/resp.13871 · Cited by 25
Wang, P., Leung, J., Lam, A., Lee, S., Calabrese, D. R., Hays, S. R., Golden, J. A., Kukreja, J., Singer, J. P., Wolters, P. J., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.11.012 · Cited by 24
Salem, I. H., Dubé, J., Boulet, L. ‐., & Chakir, J. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12611 · Cited by 25
Candidate genes of idiopathic pulmonary fibrosis: current evidence and research
Wang, Y., & Zhou, W. (2016) · The Application of Clinical Genetics · doi:10.2147/tacg.s61999 · Cited by 23
Kokosi, M. A., Margaritopoulos, G. A., & Wells, A. U. (2018) · European Respiratory Review · doi:10.1183/16000617.0117-2017 · Cited by 27
Genetic architecture of human fibrotic diseases: disease risk and disease progression
Gardet, A., Zheng, T. S., & Viney, J. L. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00159 · Cited by 24
Pulmonary surfactant: ultrastructural features and putative mechanisms of aging.
Walski, M., Pokorski, M., Antosiewicz, J., Rekawek, A., Frontczak‐Baniewicz, M., Jernajczyk, U., & Giulio, C. D. (2009) · PubMed · Cited by 23
Telomeres do the (un)twist: Helicase actions at chromosome termini
Chavez, A., Tsou, A. M., & Johnson, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.008 · Cited by 25
Innovative approaches to the therapy of fibrosis
de Andrade, J. A., & Thannickal, V. J. (2009) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328330da9b · Cited by 24
Oxidative Stress and Pulmonary Fibrosis
Manni, M. L., & Oury, T. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_122 · Cited by 24
Time-resolved proteome and transcriptome of paraquat-induced pulmonary fibrosis
Fan, L., Li, Y., Zhang, X., Wu, Y., Song, Y., Zhang, F., Zhang, J., & Sun, H. X. (2022) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2022.102145 · Cited by 23
Tometten, M., Kirschner, M., Meyer, R., Begemann, M., Halfmeyer, I., Vieri, M., Kricheldorf, K., Maurer, A., Platzbecker, U., Radsak, M. P., et al. (2023) · HemaSphere · doi:10.1097/hs9.0000000000000874 · Cited by 25
“Based on the initially assigned underlying diagnosis by the participating physicians, we divided the patients into 6 diagnostic screening categories: (1) patients with AA or PNH or AA/PNH overlap syndrome; (2) unexplained cytopenia; (3) DKC/TBD/screening family members of known DKC patients; (4) myelodysplastic syndro…”
BackgroundMethodTelomeres: Dysfunction, Maintenance, Aging and Cancer
Liao, P., Yan, B., Wang, C., & Lei, P. (2023) · Aging and Disease · doi:10.14336/ad.2023.1128 · Cited by 36
“Last but not least, adult-onset lung disorders like emphysema and pulmonary fibrosis are the most common kind of TBD [282,290,291].”
Intersection of Inflammation and Senescence in the Aging Lung Stem Cell Niche
Allen, N. C., Reyes, N. S., Lee, J. Y., & Peng, T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.932723 · Cited by 25
“Further supporting this connection is that many individuals with sporadic IPF have also been found to have short telomeres (Alder et al., 2008).”
BackgroundNatalini, J. G., England, B. R., Baker, J. F., Chen, Q., Singh, N., Mahajan, T., Roul, P., Thiele, G. M., Sauer, B. C., Mikuls, T. R., et al. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106943 · Cited by 22
MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study
Kim, J. S., Manichaikul, A. W., Hoffman, E. A., Balte, P., Anderson, M. R., Bernstein, E. J., Madahar, P., Oelsner, E. C., Kawut, S. M., Wysoczanski, A., et al. (2022) · Thorax · doi:10.1136/thorax-2021-218139 · Cited by 22
Idiopathic pulmonary fibrosis: Diagnosis, biomarkers and newer treatment protocols
Patel, H., Shah, J. R., Patel, D., Avanthika, C., Jhaveri, S., & Gor, K. (2022) · Disease-a-Month · doi:10.1016/j.disamonth.2022.101484 · Cited by 25
Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers
Drakopanagiotakis, F., Markart, P., & Steiropoulos, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210196 · Cited by 25
Budd, D. C., & Holmes, A. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.06.001 · Cited by 26
Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer
Antoniou, K. M., Samara, K. D., Lasithiotaki, I., Margaritopoulos, G. A., Soufla, G., Lambiri, I., Giannarakis, I., Drositis, I., Spandidos, D. A., & Siafakas, N. M. (2013) · Oncology Reports · doi:10.3892/or.2013.2753 · Cited by 22
“Certain data indicate that shorter telomeres in peripheral blood lymphocytes positively correlate with telomere length measured in alveolar epithelial cells from the same individuals (29).”
BackgroundHabiel, D. M., Hohmann, M. S., Espíndola, M. S., Coelho, A. L., Jones, I. C., Jones, H. D., Carnibella, R. P., Pinar, I. P., Werdiger, F., & Hogaboam, C. M. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0922-7 · Cited by 22
The Regenerative Power of Stem Cells: Treating Bleomycin-Induced Lung Fibrosis
Vats, A., & Chaturvedi, P. (2023) · Stem Cells and Cloning Advances and Applications · doi:10.2147/sccaa.s419474 · Cited by 28
Borie, R., Kannengiesser, C., & Crestani, B. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328356b15c · Cited by 22
Ascher, K. B., Elliot, S. J., Rubio, G. A., & Glassberg, M. K. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.07.001 · Cited by 22
Kawasaki, A., Namba, N., Sada, K., Hirano, F., Kobayashi, S., Nagasaka, K., Sugihara, T., Ono, N., Fujimoto, T., Kusaoi, M., et al. (2020) · Arthritis Research & Therapy · doi:10.1186/s13075-020-02347-0 · Cited by 21
“Moreover, rs2736100A was associated with shorter leukocyte telomere length [28], previously shown to contribute to risk of IPF [29].”
BackgroundExtrahematopoietic manifestations of the short telomere syndromes
Schratz, K. E. (2020) · Hematology · doi:10.1182/hematology.2020000170 · Cited by 22
BAL Transcriptomes Characterize Idiopathic Pulmonary Fibrosis Endotypes With Prognostic Impact
Sadeleer, L. D., Verleden, S. E., Schupp, J. C., McDonough, J. E., Goos, T., Yserbyt, J., Bargagli, E., Rottoli, P., Kaminski, N., Prasse, A., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2021.12.668 · Cited by 27
Using bioinformatics approach identifies key genes and pathways in idiopathic pulmonary fibrosis
Xu, Z., Mo, L., Feng, X., Huang, M., & Li, L. (2020) · Medicine · doi:10.1097/md.0000000000022099 · Cited by 20
“However, in East Asia and South America, the prevalence of IPF is lower.([15]) The pathological process of patients with IPF after initial diagnosis is complex, and the prognosis is poor overall([16]); the average survival time of patients with IPF is only about 3.”
BackgroundCombined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally
Gredic, M., Karnati, S., Ruppert, C., Guenther, A., Avdeev, S. N., & Kosanovic, D. (2023) · Cells · doi:10.3390/cells12091278 · Cited by 20
Veraldi, K. L., & Feghali-Bostwick, C. A. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010140 · Cited by 21
“This is the case in IPF, which has been recognized for decades to increase in prevalence with age [52, 53] and more recently has been associated with short telomeres and with telomerase mutations in the familial form [54-58].”
Kawashima, M., Kawakita, T., Maida, Y., Kamoi, M., Ogawa, Y., Shimmura, S., Masutomi, K., & Tsubota, K. (2011) · PubMed Central · Cited by 20
Fernandez, R. J., Gardner, Z., Slovik, K. J., Liberti, D. C., Estep, K. N., Yang, W., Chen, Q., Santini, G. T., Perez, J. V., Root, S., et al. (2022) · eLife · doi:10.7554/elife.64430 · Cited by 20
Valenti, L. V. C., Dongiovanni, P., Maggioni, M., Motta, B. M., Rametta, R., Milano, M., Fargion, S. R., Reggiani, P., & Fracanzani, A. L. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.011 · Cited by 19
“As loss-of-function mutations in the telomerase (TERT) gene are responsible, in combination with environmental factors, for a significant proportion of cases of familial idiopathic pulmonary fibrosis [4,5], the patient was tested at the Department of Internal Medicine, University of Milan, and the c.”
Zhang, Y., Calado, R. T., Rao, M., Hong, J. A., Meeker, A. K., Dumitriu, B., Atay, S. M., McCormick, P. J., Garfield, S. H., Wangsa, D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101010 · Cited by 19
“In this regard our findings are consistent with previously published studies demonstrating no significant decrease in telomerase catalytic activity by TRAPeze or direct primer extension assays [50,51].”
ResultPeters‐Hall, J. R., Min, J., Tedone, E., Sho, S., Siteni, S., Mender, I., & Shay, J. W. (2019) · The FASEB Journal · doi:10.1096/fj.201902376r · Cited by 20
Iasella, C. J., Winters, S. A., Kois, A. K., Cho, J., Hannan, S. J., Koshy, R., Moore, C. A., Ensor, C. R., Lendermon, E. A., Morrell, M. R., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15756 · Cited by 18
Self-citationTomos, I. P., Karakatsani, A., Manali, E. D., Kottaridi, C., Spathis, A., Argentos, S., & Papiris, S. A. (2020) · Pulmonology · doi:10.1016/j.pulmoe.2020.11.005 · Cited by 20
“Also, they found that IIPs patients had shorter telomeres both in peripheral blood and in the lung compared to age-matched controls.(6) It remains uncertain whether CPFE represents a distinct entity, or is a coincidental presence of two smoking-related conditions, such as emphysema and fibrosis.”
BackgroundResultInfluentialImran, S. A. M., Yazid, M. D., Idrus, R. B. H., Maarof, M., Nordin, A., Razali, R. A., & Lokanathan, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083888 · Cited by 20
“various diseases, such as dyskerato is congenita [11–13], pulmonary fibrosis [14,15], and”
BackgroundUnderstanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs
van Moorsel, C. H. M., Hoffman, T. W., van Batenburg, A. A., Klay, D., van der Vis, J. J., & Grutters, J. C. (2015) · BioMed Research International · doi:10.1155/2015/304186 · Cited by 19
“Leukocytes telomere lengths in cohorts of FIP and sporadic IIP patients were significantly shorter compared to age-matched controls [60, 61].”
ResultInterstitial lung disease in the elderly: pathogenesis, diagnosis and management.
Meyer, K. C. (2011) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 21
Calado, R. T. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00008-6 · Cited by 20
“intense, and other genetic, epigenetic, and environmental factors also play a role in disease progression.(23) In a series of 134 heterozygous TERTmutation carriers in 21 unrelated families, IPF was age-dependent and not 177 Telomeres in Lung Diseases”
BackgroundInfluentialPlasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis
Min, H., Fan, S., Song, S., Zhuang, Y., Li, H., Wu, Y., Cai, H., Yi, L., Dai, J., & Gao, Q. (2016) · Diagnostic Pathology · doi:10.1186/s13000-016-0583-2 · Cited by 19
“is a risk factor for the survival of IPF [16, 30].”
BackgroundShall we call them “telomere-mediated”? Renaming the idiopathic after the cause is found
Merck, S. J., & Armanios, M. Y. (2016) · European Respiratory Journal · doi:10.1183/13993003.02115-2016 · Cited by 18
Self-citationOmote, N., & Sauler, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.603047 · Cited by 17
Idiopathic Pulmonary Fibrosis and Telomeres
Mulet, A., & Signes‐Costa, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236893 · Cited by 22
Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective
Papiris, S. A., Kannengiesser, C., Borie, R., Kolilekas, L., Kallieri, M., Apollonatou, V., Ba, I., Nathan, N., Bush, A., Griese, M., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12122928 · Cited by 20
Exercise as a Therapy to Maintain Telomere Function and Prevent Cellular Senescence
Kim, J., Ahn, A., Ying, J. Y., Hickman, E., & Ludlow, A. T. (2023) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000324 · Cited by 19
“Telomere length follows a normal distribution, meaning that a shorter mean telomere length is not necessarily indicative of a greater number of critically short telomeres that could induce cellular senescence (59).”
BackgroundImpact of a Prospective Review Program for Reference Laboratory Testing Requests
Greenblatt, M. B., Nowak, J. A., Quade, C. C., Tanasijevic, M. J., Lindeman, N. I., & Jarolím, P. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpn1vczdvd9zvx · Cited by 17
Short and dysfunctional telomeres protect from allergen‐induced airway inflammation
Piñeiro‐Hermida, S., Martínez, P., & Blasco, M. A. (2021) · Aging Cell · doi:10.1111/acel.13352 · Cited by 18
“Telomerase (TERT) mutations result in extremely short telomeres and have been associated with the clinical manifestations of several respiratory pathologies including idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease (Alder et al., 2008; Stanley et al., 2015).”
BackgroundInsights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases
Wang, J. Y., & Young, L. R. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0557tr · Cited by 20
Loss of ELK1 has differential effects on age-dependent organ fibrosis
Cairns, J. T., Habgood, A., Edwards-Pritchard, R. C., Joseph, C., John, A. E., Wilkinson, C., Stewart, I. D., Leslie, J., Blaxall, B. C., Suszták, K., et al. (2019) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2019.105668 · Cited by 23
“IPF specifically, and fibrotic diseases more generally, affect primarily the elderly and have been associated with age-related processes such as telomere shortening (Cronkhite et al., 2008; Armanios et al., 2007; Alder et al., 2008).”
BackgroundSullivan, D. I., Jiang, M., Hinchie, A. M., Roth, M. G., Bahudhanapati, H., Nouraie, M., Liu, J., McDyer, J. F., Mallampalli, R. K., Zhang, Y., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.600626 · Cited by 16
“Approximately half of sporadic and >60% of familial cases of IPF have short telomeres (20).”
BackgroundSelf-citationAir pollution and alveolar health
Sofia, C., Parkin, J. G. H., Bell, J. A., Dean, L. S. N., Edgeway, L. J., Sayer, L. N., Easton, N. H. C., Davies, D. E., Marshall, B. G., Holgate, S. T., et al. (2025) · European Respiratory Review · doi:10.1183/16000617.0280-2024 · Cited by 23
“Studies have demonstrated abnormally shortened telomeres in some fibrotic ILDs [120, 121].”
Zhang, K., Wang, L., Hong, X., Chen, H., Shi, Y., Liu, Y., Liu, J., & Liu, J. (2021) · Cells · doi:10.3390/cells10112892 · Cited by 18
Wanas, H., Shereef, Z. E., Rashed, L. A., & Aboulhoda, B. E. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210204212533 · Cited by 18
Sala, M. A., Balderas-Martínez, Y. I., Buendía-Roldán, I., Abdala‐Valencia, H., Nam, K.-W., Jain, M., Bhorade, S. M., Bharat, A., Reyfman, P. A., Ridge, K. M., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0932-7 · Cited by 18
Treatment of lymphedema and patient rehabilitation.
Földi, E. (1998) · PubMed · Cited by 16
(2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200903-0483ed · Cited by 16
Park, M. Y., Bae, S., Heo, J. A., Park, M., Kim, Y., Han, J., Jang, I., Yu, K., & Oh, J. (2023) · Clinical and Translational Science · doi:10.1111/cts.13518 · Cited by 15
Τzouvelekis, Α., Aidinis, V., Harokopos, V., Karameris, A., Zacharis, G., Mikroulis, D. A., Konstantinou, F., Steiropoulos, P., Sotiriou, I., Froudarakis, Μ. E., et al. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-14 · Cited by 18
“Whether patients with sporadic or familial IPF present with mutations in Ing4, as it happens with telomerase [36-39], and whether these mutations affect ING4 expression and are associated with patients' survival and treatment response, remains to be proven.”
BackgroundUnclassifiable interstitial lung disease: a pathologist's perspective
Jones, K. D. (2018) · European Respiratory Review · doi:10.1183/16000617.0132-2017 · Cited by 15
Insights gained in the pathology of lung disease through single‐cell transcriptomics
Carraro, G., & Stripp, B. R. (2022) · The Journal of Pathology · doi:10.1002/path.5971 · Cited by 17
“Several molecular changes in type 2 pneumocytes can be associated with senescence and an increased risk for IPF, including mutations in genes involved in maintenance of proper telomere length and oxidative stress [24,25].”
BackgroundRecent advances in the genetics of idiopathic pulmonary fibrosis
Spagnolo, P., & Lee, J. S. (2023) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000989 · Cited by 18
Therapeutic Update in Idiopathic Pulmonary Fibrosis
Chan, A. L., Rafii, R., Louie, S., & Albertson, T. E. (2011) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8244-9 · Cited by 16
“This pattern therefore suggests currently unidentified genetic abnormalities in a higher proportion of patients [24, 25].”
BackgroundDynamics of telomeric chromatin at the crossroads of aging and cancer
Ye, J., Wu, Y., & Gilson, É. (2010) · Essays in Biochemistry · doi:10.1042/bse0480147 · Cited by 17
Serum Telomerase Levels and COPD Exacerbations
Bozkuş, F., Güler, S., & Şimşek, S. (2016) · Respiratory Care · doi:10.4187/respcare.04389 · Cited by 16
PINX1 and TERT Are Required for TNF-α–Induced Airway Smooth Muscle Chemokine Gene Expression
Deacon, K., & Knox, A. J. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700414 · Cited by 16
“Airway fibroblasts from patients with interstitial lung disease and idiopathic pulmonary fibrosis have altered telomerase activity (27, 28), but this study did not assess the effect of TERT inhibition on idiopathic pulmonary fibrosis physiology.”
BackgroundLettieri, S., Bertuccio, F. R., Frate, L. D., Perrotta, F., Corsico, A. G., & Stella, G. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010547 · Cited by 17
“These FF, which are composed of clusters of actively growing fibroblasts and myofibroblasts, are located next to sites of injury to basement membranes and epithelial cells [33].”
BackgroundGoobie, G. C., Marinescu, D.-C., Adegunsoye, A., Bourbeau, J., Carlsten, C., Clifford, R. L., Doiron, D., Duan, Q., Gibson, K. F., Grant-Orser, A., et al. (2025) · European Respiratory Journal · doi:10.1183/13993003.01618-2024 · Cited by 15
Update of Aging Hallmarks in Idiopathic Pulmonary Fibrosis
Torres‐Machorro, A. L., García-Vicente, Á., Espina-Ordoñez, M., Luis‐García, E. R., Negreros, M., Herrera, I., Becerril, C., Toscano-Marquez, F., Cisneros, J., & Maldonado, M. (2025) · Cells · doi:10.3390/cells14030222 · Cited by 19
Popper, H., Stacher‐Priehse, E., Brčić, L., & Nerlich, A. (2021) · Rheumatology International · doi:10.1007/s00296-021-05002-2 · Cited by 14
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?
Lettieri, S., Oggionni, T., Lancia, A., Bortolotto, C., & Stella, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062882 · Cited by 16
“It is known that inherited mutations of TERC and TERT genes are associated with 8–20% of familial IPF and with 1% of sporadic IPF [55,59,60].”
BackgroundYoung, O. N., Bourke, J. E., & Widdop, R. E. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115839 · Cited by 17
Rong, H., He, X., Zhu, L., Zhu, X., Kang, L., Wang, L., He, Y., Yuan, D., & Jin, T. (2017) · Medicine · doi:10.1097/md.0000000000008222 · Cited by 15
Sivley, R. M., Sheehan, J. H., Kropski, J. A., Cogan, J. D., Blackwell, T. S., Phillips, J. A., Bush, W. S., Meiler, J., & Capra, J. A. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2010-z · Cited by 13
“org/publicdomain/ze cause is unknown, such as with idiopathic pulmonary fibrosis, telomere shortening in peripheral blood mononuclear cells [9–11] and type II alveolar epithelial cells [6, 11] is commonly observed in patients and families.”
BackgroundSelf-citationStuck in a Moment: Does Abnormal Persistence of Epithelial Progenitors Drive Pulmonary Fibrosis?
Auyeung, V. C., & Sheppard, D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3898ed · Cited by 17
“Telomere maintenance defects may be common in sporadic IPF as well (10).”
BackgroundStanel, S. C., Callum, J., & Rivera‐Ortega, P. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1232655 · Cited by 15
“, increased liver transaminases) can also be found in 5–27% TRG mutation patients and early hair greying is noted in 15–40% (11, 19).”
BackgroundTelomere biology disorders may manifest as common variable immunodeficiency (CVID)
Rolles, B., Caballero-Oteyza, A., Proietti, M., Goldacker, S., Warnatz, K., Camacho-Ordóñez, N., Prader, S., Schmid, J. P., Vieri, M., Isfort, S., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109837 · Cited by 17
Henriques, C. M., & Ferreira, M. G. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050581 · Cited by 15
De Meyer, T. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31822ed876 · Cited by 13
“Although buccal cell telomere biology might differ from that of white blood cells, buccal cell telomere length is highly correlated with blood telomere length (35), has also been reported to be associated with age-related disease (36), and importantly, does not require the (in children) relatively invasive blood colle…”
BackgroundClub Cell Loss as a Feature of Bronchiolization in ILD
Reynaud, P., Ahmed, E., Serre, I., Knabe, L., Bommart, S., Suehs, C., Vachier, I., Berthet, J. P., Romagnoli, M., Vernisse, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.630096 · Cited by 13
“Senescence may play a key role in the fibrotic process characteristic of UIP (22) possibly via this bronchiolization.”
BackgroundOseini, A. M., Hamilton, J. P., Hammami, M. B., Kim, A., Oshima, K., Woreta, T. A., Rizkalla, N. A., Pustavoitau, A., Merlo, C. A., Nguyen, M., et al. (2021) · Liver Transplantation · doi:10.1002/lt.26109 · Cited by 13
Self-citationIs Acute Fibrinous and Organizing Pneumonia the Expression of Immune Dysregulation?
Labarinas, S., Gumy‐Pause, F., Rougemont, A., Baerlocher, G. M., Leibundgut, E. O., Porret, N. A., Schäppi, M. G., Barazzone‐Argiroffo, C., Passweg, J. R., Merlini, L., et al. (2013) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e31827e5782 · Cited by 13
Road ahead to respiratory health: Experts chart future research directions
Heffner, J. E., Holgate, S. T., Chung, K. F., Niederman, M. S., Daley, C. L., Jett, J. R., Stradling, J. R., Wells, A. U., Light, R. W., Tapson, V. F., et al. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01484.x · Cited by 13
Avdeev, S. N. (2015) · PULMONOLOGIYA · doi:10.18093/0869-0189-2015-25-5-600-612 · Cited by 15
Update in Diffuse Parenchymal Lung Disease 2008
Behr, J., & Thannickal, V. J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0011up · Cited by 13
van Batenburg, A. A., Kazemier, K. M., Peeters, T., van Oosterhout, M. F. M., van der Vis, J. J., Grutters, J. C., Goldschmeding, R., & van Moorsel, C. H. M. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155418761351 · Cited by 13
Senhaji, L., Senhaji, N., Abbassi, M., Karhate, M., Serraj, M., Biaze, M. E., Benjelloun, M. C., Ouldim, K., Bouguenouch, L., & Amara, B. (2026) · Biomedicines · doi:10.3390/biomedicines14010090 · Cited by 14
Idiopathic Pulmonary Fibrosis: From Common Microscopy to Single-Cell Biology and Precision Medicine
Selman, M., & Pardo, A. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202309-1573pp · Cited by 14
Metadata
- Authors
- Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., Phillips, J. A., Lansdorp, P. M., Loyd, J. E., & Armanios, M. Y.
- Affiliations
- Johns Hopkins University (US)
- Arizona State University (US)
- Vanderbilt University (US)
- BC Cancer Agency (CA)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2008-09-02
- Volume
- 105
- Issue
- 35
- Pages
- 13051-13056
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2529100
- OpenAlex
- W2147238277
- Cited by
- 805
- References
- 35
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 38 · 2023: 48 · 2022: 45 · 2021: 61 · 2020: 53 · 2019: 60 · 2018: 54 · 2017: 40 · 2016: 36 · 2015: 56 · 2014: 45 · 2013: 45 · 2012: 40
- FWCI
- 33.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Doris Duke Charitable Foundation
- Johns Hopkins University
- National Institutes of Health
- U.S. Public Health Service (T32 60441, K08 118416)
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, idiopathic interstitial pneumonia, telomere length, short telomeres, telomerase mutations, hTERT, hTR, leukocytes, alveolar epithelial cells, cryptogenic cirrhosis, disease risk
- MeSH terms
- Epithelium, Family, Fibrosis, Heterozygote, Humans, Leukocytes, Mononuclear, Pulmonary Alveoli, Pulmonary Fibrosis, Risk Factors, RNA, Tomography, X-Ray Computed, Biomarkers, Case-Control Studies, Telomere, In Situ Hybridization, Fluorescence, Germ-Line Mutation, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.